News tagged with haematology
Hematology, also spelled haematology (from the Greek αἷμα haima "blood" and -λoγία), is the branch of biology physiology, internal medicine, pathology, clinical laboratory work, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. The laboratory work that goes into the study of blood is frequently performed by a medical technologist. Hematologists physicians also very frequently do further study in oncology - the medical treatment of cancer.
Blood diseases affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, the mechanism of coagulation, etc.
Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results. In some institutions, hematologists also manage the hematology laboratory. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists. Hematologists and hematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate therapy if needed. Hematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. Hematologists may specialize further or have special interests, for example in:
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
A study of the cells that respond to crises in the blood system has yielded a few surprises, redrawing the 'map' of how blood cells are made in the body.
Medical research Jan 31, 2012 | 5 / 5 (2) | 0 |
Melbourne researchers have discovered that acute myeloid leukaemia (AML), an aggressive blood cancer with poor prognosis, may be susceptible to medications that target a protein called Mcl-1.
Genetics Jan 17, 2012 | 5 / 5 (1) | 0
Parents of children in the palliative stage of cancer favour aggressive chemotherapy over supportive care compared with health care professionals, states an article in CMAJ (Canadian Medical Association Journal).
Health Oct 17, 2011 | not rated yet | 0
Transplantation of haematopoietic stem cells is an effective treatment for patients with malignant blood diseases. The composition and quality of the transplanted cells are crucial to the outcome. Researchers from Lund University, ...
Medical research Sep 06, 2011 | not rated yet | 0 |
Old red blood cells shown to have undergone ?significant changes and damage?; techniques could help rapidly monitoring quality of blood supply.
Medical research May 20, 2011 | not rated yet | 0 |